A study from Washington University in St. Louis found taking suvorexant, a common insomnia medication, for two nights ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

What if the solution to Alzheimer’s disease lies not in combating the proteins that cause it, but in simply getting more ...

The once-monthly injection is intended for adults with early symptomatic Alzheimer’s disease. This is the first medication to ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

The Alzheimer's epidemic continues to cast a shadow over the lives of millions of people. With no effective treatment ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

Scientists from Boston University and other institutions have identified a blood biomarker that could help detect the ...

Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...

In a year plagued by the challenges of Alzheimer's disease, 2024 brought a glimmer of hope with the approval of the third new ...

This review provides an overview of Alzheimer’s disease (AD), discussing its complex pathophysiology, risk factors, and ...

thh.nhs.uk The amyloidoses are a group of diseases in which amyloid, a proteinaceous substance, deposits in one or more organs. As many as 23 different precursor proteins to the formation of amyloid ...